Literature DB >> 21483467

Human Cytomegalovirus (HCMV) - Revised.

Volkmar Schottstedt1, Johannes Blümel, Reinhard Burger, Christian Drosten, Albrecht Gröner, Lutz Gürtler, Margarethe Heiden, Martin Hildebrandt, Bernd Jansen, Thomas Montag-Lessing, Ruth Offergeld, Georg Pauli, Rainer Seitz, Uwe Schlenkrich, Johanna Strobel, Hannelore Willkommen, Carl-Heinz Wirsing von König.   

Abstract

Entities:  

Year:  2010        PMID： 21483467      PMCID： PMC3048947          DOI： 10.1159/000322141

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  105 in total

1.  Asymptomatic primary cytomegalovirus infection: virologic and immunologic features.

Authors:  F Zanghellini; S B Boppana; V C Emery; P D Griffiths; R F Pass
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

2.  Congenital and perinatal infections with cytomegalovirus.

Authors:  D E Trincado; W D Rawlinson
Journal:  J Paediatr Child Health       Date:  2001-04       Impact factor: 1.954

3.  High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.

Authors:  Malte Ziemann; Sabine Krueger; Andrea B Maier; Alexander Unmack; Siegfried Goerg; Holger Hennig
Journal:  Transfusion       Date:  2007-11       Impact factor: 3.157

4.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

5.  A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression.

Authors:  K Asadullah; S Prösch; H Audring; I Büttnerova; H D Volk; W Sterry; W D Döcke
Journal:  Br J Dermatol       Date:  1999-07       Impact factor: 9.302

6.  Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.

Authors:  G L Gilbert; K Hayes; I L Hudson; J James
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

Review 7.  CMV and blood transfusions.

Authors:  John D Roback
Journal:  Rev Med Virol       Date:  2002 Jul-Aug       Impact factor: 6.989

Review 8.  CMV-specific T cell therapy.

Authors:  Hermann Einsele; Markus Kapp; Götz Ulrich Grigoleit
Journal:  Blood Cells Mol Dis       Date:  2007-09-11       Impact factor: 3.039

9.  Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.

Authors:  H Rubie; M Attal; A M Campardou; C Gayet-Mengelle; C Payen; F Sanguignol; J P Calot; J P Charlet; A Robert; F Huguet
Journal:  Bone Marrow Transplant       Date:  1993-03       Impact factor: 5.483

10.  The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.

Authors:  Milind D Ronghe; Annabel B M Foot; Jaqueline M Cornish; Colin G Steward; David Carrington; Nicholas Goulden; David I Marks; Anthony Oakhill
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998
View more
  28 in total

Review 1.  Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy?

Authors:  Malte Ziemann; Holger Hennig
Journal:  Transfus Med Hemother       Date:  2013-12-19       Impact factor: 3.747

2.  Vaccine Formulation and Optimization for Human Herpes Virus-5 through an Immunoinformatics Framework.

Authors:  Neeraj Kumar; Damini Sood; Ramesh Chandra
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-19

3.  Cell type-specific biogenesis of novel vesicles containing viral products in human cytomegalovirus infection.

Authors:  Samina Momtaz; Belen Molina; Luwanika Mlera; Felicia Goodrum; Jean M Wilson
Journal:  J Virol       Date:  2021-03-24       Impact factor: 5.103

4.  Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus.

Authors:  Zeina Nehme; Sébastien Pasquereau; Sandy Haidar Ahmad; Ranim El Baba; Georges Herbein
Journal:  EBioMedicine       Date:  2022-05-18       Impact factor: 11.205

5.  Global analysis of differential expressed genes in ECV304 Endothelial-like cells infected with human cytomegalovirus.

Authors:  Mo Xiaoyang; Z Haiquan; Z Huanying; K Changwen; Z Wenling; Tu Yanyang; Z Yongsheng
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

6.  Erratum: Differential expressed genes in ECV304 Endothelial-like Cells infected with Human Cytomegalovirus.

Authors:  Yali Zhang; Wenli Ma; Xiaoyang Mo; Haiquan Zhao; Huanying Zheng; Changwen Ke; Wenling Zheng; Yanyang Tu; Yongsheng Zhang
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

Review 7.  Infections at the nexus of metabolic-associated fatty liver disease.

Authors:  Robim M Rodrigues; Tamara Vanhaecke; Joost Boeckmans; Matthias Rombaut; Thomas Demuyser; Baptist Declerck; Denis Piérard; Vera Rogiers; Joery De Kock; Luc Waumans; Koen Magerman; Reinoud Cartuyvels; Jean-Luc Rummens
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

8.  β-HHVs and HHV-8 in Lymphoproliferative Disorders.

Authors:  C Quadrelli; P Barozzi; G Riva; D Vallerini; E Zanetti; L Potenza; F Forghieri; M Luppi
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576

9.  Unusually difficult clinical presentation of an infant suffering from congenital Cytomegalovirus (CMV) infection combined with alpha 1-antitrypsin (A1AT) deficiency.

Authors:  Ines Potočnjak; Goran Tešović; Andrea Tešija Kuna; Mario Stefanović; Orjena Zaja
Journal:  Biochem Med (Zagreb)       Date:  2014-10-15       Impact factor: 2.313

10.  Association of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomas

Authors:  Hamide Mehravaran; Manoochehr Makvandi; Alireza Samarbaf Zade; Niloofar Neisi; Hadis Kiani; Hashem Radmehr; Toran Shahani; Seyedeh Zeinab Hoseini; Nastaran Ranjbari; Rahil Nahid Samiei
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.